BIOLASE Management

BIOLDelisted Stock  USD 0.05  0.02  27.46%   
BIOLASE employs about 157 people. The company is managed by 7 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 22.43 employees per reported executive. Inspection of BIOLASE's management performance can provide insight into the company performance.
Matthew Wilson  President
Vice President of Human Resources
John Beaver  President
CFO, Senior Vice President
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

BIOLASE Management Team Effectiveness

The company has return on total asset (ROA) of (0.2682) % which means that it has lost $0.2682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.0476) %, meaning that it created substantial loss on money invested by shareholders. BIOLASE's management efficiency ratios could be used to measure how well BIOLASE manages its routine affairs as well as how well it operates its assets and liabilities.

BIOLASE Workforce Comparison

BIOLASE is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 14,572. BIOLASE claims roughly 157 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.44) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.45.

BIOLASE Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIOLASE insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIOLASE's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BIOLASE insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

BIOLASE Notable Stakeholders

A BIOLASE stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BIOLASE often face trade-offs trying to please all of them. BIOLASE's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BIOLASE's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Matthew WilsonVice President of Human ResourcesProfile
John BeaverCFO, Senior Vice PresidentProfile
David RodriguezDirector EventsProfile
Jennifer BrightChief OfficerProfile
Russell DDSChief OfficerProfile
Michael CarrollCorporate SecretaryProfile
Steven SandorChief OfficerProfile

About BIOLASE Management Performance

The success or failure of an entity such as BIOLASE often depends on how effective the management is. BIOLASE management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BIOLASE management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BIOLASE management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. Biolase operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 158 people.

BIOLASE Workforce Analysis

Traditionally, organizations such as BIOLASE use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BIOLASE within its industry.

BIOLASE Manpower Efficiency

Return on BIOLASE Manpower

Revenue Per Employee313.1K
Revenue Per Executive7M
Net Loss Per Employee131.4K
Net Loss Per Executive2.9M
Working Capital Per Employee33.1K
Working Capital Per Executive742.9K
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in BIOLASE Stock

If you are still planning to invest in BIOLASE check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BIOLASE's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Directory
Find actively traded commodities issued by global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators